Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - World Heart announces some management changes:

This article was originally published in Clinica

Executive Summary

Ontario, Canada-based pulsatile ventricular assist device provider World Heart has announced some management changes. Jal Jassawalla has been named president and CEO, effective immediately. Mr Jassawalla succeeds Roderick Bryden, who recently resigned. Piet Jansen has been appointed managing director of the firm's European business. Dr Jansen will also continue in his role as chief medical officer. John Marinchak has been named vice-president of marketing and sales. He joined World Heart in November 2003. Finally, Robert Corson, who joined the company in November 1997, has been promoted to vice-president of manufacturing, and will be based in the firm's Oakland facilities.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel